How many employees does ESSA Pharma have this year?
ESSA Pharma has 11 undefined employees this year.
ESSA Pharma Employees 2024
ESSA Pharma Employees
11
Ticker
EPIX
ISIN
CA29668H7085
WKN
A2JKQ4
In 2024, ESSA Pharma employed 11 people, a 0% change from the 11 number of employees in the previous year.
ESSA Pharma Aktienanalyse
What does ESSA Pharma do?
ESSA Pharma Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of prostate cancer and other types of cancer. The company is headquartered in Vancouver, Canada and was founded in 2009. The history of ESSA Pharma Inc begins with the discovery of a new approach to treating prostate cancer by the company's founders. They discovered that a combination of an androgen receptor inhibitor and a NEDDylation signaling inhibitor could offer a new and effective approach to treating prostate cancer. Based on this discovery, they founded ESSA Pharma Inc to further develop this therapy. ESSA Pharma Inc's business model is based on the discovery, development, and commercialization of therapies for the treatment of prostate cancer and other types of cancer. The company has a pipeline of products in various clinical phases aimed at effectively combating prostate cancer and other types of cancer. ESSA Pharma Inc operates in two main divisions: research and development, and marketing and sales. The company's research and development department is dedicated to identifying and developing new compounds tailored to the specific needs of patients with prostate cancer. The company also works closely with researchers and physicians to test the efficacy of its products in treatment protocols and clinical practice. The second division of ESSA Pharma Inc deals with the marketing and sales of its products. Here, the company works closely with pharmaceutical manufacturers and other companies to market and sell its products worldwide. The company also has its own sales department that serves customers worldwide. ESSA Pharma Inc currently offers several products in different stages of clinical trials. These include EPI-506, an androgen receptor inhibitor currently being used in a Phase 1 study for the treatment of prostate cancer, and EPI-7386, a NEDDylation signaling inhibitor currently in a Phase 1 study for the treatment of prostate cancer. In addition, ESSA Pharma Inc has formed partnerships with other companies to further develop its technology platform and pipeline of cancer therapies. For example, the company is collaborating with Bayer Healthcare to advance the development of EPI-7386. Overall, ESSA Pharma Inc is an innovative and emerging biotech company focused on the development of therapies for the treatment of prostate cancer and other types of cancer. The company is pursuing an ambitious strategy and has already achieved promising results in the development of new compounds for the treatment of prostate cancer. ESSA Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining ESSA Pharma's Employee Base
ESSA Pharma's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding ESSA Pharma's operational capacity and future potential.
Year-to-Year Comparison
Assessing ESSA Pharma's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
ESSA Pharma's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in ESSA Pharma’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about ESSA Pharma stock
How many employees did ESSA Pharma have compared to the previous year?
Compared to the previous year, ESSA Pharma had 0% more employees.
What impact did the number of employees have on the company ESSA Pharma?
The number of employees has a direct impact on the efficiency and productivity of ESSA Pharma. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of ESSA Pharma?
The number of employees can also have an impact on investors of ESSA Pharma, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of ESSA Pharma affect the company?
An increase in equity of ESSA Pharma can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in ESSA Pharma's equity affect the company?
A reduction in equity of ESSA Pharma can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of ESSA Pharma?
Some factors that can influence the equity of ESSA Pharma include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of ESSA Pharma so important for investors?
The equity of ESSA Pharma is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at ESSA Pharma influence the company?
The number of employees at ESSA Pharma can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at ESSA Pharma evolved in recent years?
In recent years, the number of employees at ESSA Pharma has changed by 0.
How many employees does ESSA Pharma currently have?
ESSA Pharma currently has 11 undefined employees.
Why is the number of employees important for investors of ESSA Pharma?
The number of employees is important for investors of ESSA Pharma as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can ESSA Pharma take to change the number of employees?
To change the number of employees, ESSA Pharma can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does ESSA Pharma pay?
Over the past 12 months, ESSA Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ESSA Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of ESSA Pharma?
The current dividend yield of ESSA Pharma is .
When does ESSA Pharma pay dividends?
ESSA Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ESSA Pharma?
ESSA Pharma paid dividends every year for the past 0 years.
What is the dividend of ESSA Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ESSA Pharma located?
ESSA Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von ESSA Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ESSA Pharma from 11/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/24/2024.
When did ESSA Pharma pay the last dividend?
The last dividend was paid out on 11/24/2024.
What was the dividend of ESSA Pharma in the year 2023?
In the year 2023, ESSA Pharma distributed 0 USD as dividends.
In which currency does ESSA Pharma pay out the dividend?
The dividends of ESSA Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von ESSA Pharma
Our stock analysis for ESSA Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ESSA Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
